drugset / Trial / NCT00556075
Safety and Efficacy Study to Evaluate Proellex in the Treatment of Premenopausal Women With Symptomatic Endometriosis
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to determine whether Proellex is safe and effective for the treatment of symptomatic endometriosis.
Timeline
- Start
- 2007-11
- Primary completion
- 2009-05
- Completion
- 2009-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Telapristone Acetate | Other / unclassified | 25 mg | — |
| Subject | Telapristone Acetate | Other / unclassified | 50 mg | — |